CN105434755A - Traditional Chinese medicine composition for treating digestive tract cancers - Google Patents
Traditional Chinese medicine composition for treating digestive tract cancers Download PDFInfo
- Publication number
- CN105434755A CN105434755A CN201511012476.8A CN201511012476A CN105434755A CN 105434755 A CN105434755 A CN 105434755A CN 201511012476 A CN201511012476 A CN 201511012476A CN 105434755 A CN105434755 A CN 105434755A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- medicine composition
- cancers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses traditional Chinese medicine composition for treating digestive tract cancers. The traditional Chinese medicine composition is prepared from the following traditional Chinese medicine raw materials by weight: 39 to 46 parts of dragon's blood, 32 to 41 parts of snow lotus herb, 26 to 34 parts of piper longum, 21 to 29 parts of Chinese olive, 16 to 24 parts of medulla stachyuri, 21 to 23 parts of fructus malvae vertillatae, 16 to 23 parts of caulis sargentodoxae, and 15 to 20 parts of natural indigo. The traditional Chinese medicine composition is obtained by conducting fine extraction on pure Chinese herbal medicine, has the obvious effects of easing pain, soothing, preventing cancers, can be used for reducing cancer nucleus division amount, and accelerating regression and necrosis of cancer nuclei, has no adverse reaction, has a certain curative effect in treating respiratory tract cancers, the digestive tract cancers and other cancers, is low in cost, safe and effective in treating of aged patients who refuse or cannot accept operative treatment or patients suffering from cardio-cerebrovascular diseases, and can be easily accepted by patients.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of alimentary tract cancer.
Background technology
Cancer is the common frdquently encountered disease be detrimental to health, and the sickness rate of wherein digestive tract cancer accounts for more than 1/4th of common cancer, and the incidence and mortality of China's digestive tract cancer is the highest.China is the severely afflicated area of digestive tract tumor, gastric cancer 400,000 person/year, various intestinal cancer 130,000 person/year, and still on the rise at present.But digestive tract tumor does not often have special symptom in early days, so near late period during great majority diagnosis, lose treatment chance, bring massive losses to family and individual, have a strong impact on people's lives health.
At present, the method for Therapeutic cancer is generally radiotherapy chemotherapy and operative treatment, but due to after cancer discovery, mostly belongs to middle and advanced stage, namely lose the opportunity of operative treatment, also limit effective application of radiotherapy chemotherapy simultaneously.Chinese traditional treatment cancer has had the history of more than 2,000 year, have accumulated abundant theory and practice experience, to relief of symptoms, improve body constitution, improve life quality, the effect of extending life is subject to most attention, is acknowledged as the primary treatments for the treatment of middle and terminal cancer patient.But, also do not develop a kind of medicine of desirable treatment alimentary tract cancer at present.
Summary of the invention
The object of the present invention is to provide composition of medicine being used for the treatment of alimentary tract cancer that a kind of curative effect is high, cost is low, no pain, toxic and side effects are little, easy to use and preparation method thereof.
For solving the problems of the technologies described above, the technical solution used in the present invention is:
A kind of Chinese medicine composition for the treatment of alimentary tract cancer provided by the invention, is made up of the raw material of Chinese medicine of following weight portion: Sanguis Draxonis 39-46 part, Semen Strychni 32-41 part, BIBO 26-34 part, Fructus Canarii 21-29 part, Medulla Stachyuri (Medulla Helwingiae) 16-24 part, Fructus Malvae 23-21 part, Caulis seu Radix Schisandrae Henryi 16-23 part, Indigo Naturalis 15-20 part.
Preferably, Chinese medicine provided by the invention is made up of the raw material of Chinese medicine of following weight portion: Sanguis Draxonis 46 parts, Semen Strychni 41 parts, BIBO 34 parts, Fructus Canarii 29 parts, Medulla Stachyuri (Medulla Helwingiae) 24 parts, Fructus Malvae 21 parts, Caulis seu Radix Schisandrae Henryi 23 parts, Bombyx Batryticatus 18 parts.
Usage and consumption: adopt conventional Chinese medicine decocting method to decoct water, take, every day 1 dose, point take for 2 times, within 20 days, is a course for the treatment of, generally take 3-6 the course for the treatment of successful.
Clinical verification:
1, case selection: 150 routine patients with cancer in digestive tracts.
2, Therapeutic Method: take composition of medicine of the present invention, adopts conventional Chinese medicine decocting method to decoct water, takes, every day 1 dose, point takes for 2 times, within 20 days, is a course for the treatment of, generally take 3-6 the course for the treatment of successful.
3, criterion of therapeutical effect
Clinical cure, refers to that the positive sign of symptom and objective determination disappears, recovers certain work capacity, and Continuous Observation 1 year is without recidivist.
Clinical effective, refer to that symptom disappears substantially, focus reduces more than 1 half, and other objective determinations are clearly better, and Continuous Observation half a year is without development person.
Effectively clinical, refer to that symptom makes moderate progress, focus is basicly stable, observes more than January without development person.
Clinical invalid, refer to that symptom and objective determination are without improvement, or only have short-term to improve, and deterioration person rapidly.
4, experimental result: clinical cure rate 65%, clinical obvious effective rate 83%, clinical effective rate 97%; Clinical inefficiency only has 3%.
Beneficial effect of the present invention:
Pharmaceutical purity medium-height grass YAOJING of the present invention is carried, and has obvious analgesia, calmness and antitumaous effect; The minimizing of cancerous cell karyokinesis quantity, regression and necrosis are serious; Without any untoward reaction; To respiratory tract, digestive tract and other cancers, there is certain curative effect; With low cost, provide therapeutic modality safely and effectively for the old age of being reluctant maybe cannot be treated surgically or Patients with Cardiovascular/Cerebrovascular Diseases, patient is easy to accept.
Detailed description of the invention
Embodiment 1
A kind of Chinese medicine composition for the treatment of alimentary tract cancer that the present embodiment provides, is made up of the raw material of Chinese medicine of following weight portion: Sanguis Draxonis 46 parts, Semen Strychni 41 parts, BIBO 34 parts, Fructus Canarii 29 parts, Medulla Stachyuri (Medulla Helwingiae) 24 parts, Fructus Malvae 21 parts, Caulis seu Radix Schisandrae Henryi 23 parts, Bombyx Batryticatus 18 parts.
Usage and consumption: adopt conventional Chinese medicine decocting method to decoct water, take, every day 1 dose, point take for 2 times, within 20 days, is a course for the treatment of, generally take 3-6 the course for the treatment of successful.
Model case:
Case 1: Zhao, female, 77 years old, diet was swallowed not smooth, retrosternal pain, cancer of late stage, and fluid does not feel like eating yet; Can eat after taking 4 courses for the treatment of of Chinese medicine of the present invention and continue to take 6 courses for the treatment of, again biopsies, not be checked through cancerous cell, do not recur so far.
Case 2: Ma, man, 75 years old, cancer late period, eats and just tells; Superior lobe of left lung scale cancer, because leukocyte is on the low side, body constitution is not suitable for operation, carries out radiotherapy, can eat, continue to take after taking 4 courses for the treatment of of Chinese medicine of the present invention, and 4 courses for the treatment of cure.
Case 3: punishment, man, 74 years old, advanced esophageal cancer, was no longer capable of either eating or drinking, the cancer of the esophagus reflux several months, can eat to continue to take 5 courses for the treatment of and substantially recover normal after taking 5 courses for the treatment of of Chinese medicine of the present invention.
Case 4: gold certain, man, 65 years old, 2 stomach nine supportted difficult general weakness, and complexion is gloomy, and when yellow hair is done all of a sudden, also cardiopalmus is for the sleeping several months, can eat, suitably can leave the bed, continue to take 5 courses for the treatment of and substantially recover normal after taking 5 courses for the treatment of of Chinese medicine of the present invention.
Claims (2)
1. treat a Chinese medicine composition for alimentary tract cancer, it is characterized in that, be made up of the raw material of Chinese medicine of following weight portion: Sanguis Draxonis 39-46 part, Semen Strychni 32-41 part, BIBO 26-34 part, Fructus Canarii 21-29 part, Medulla Stachyuri (Medulla Helwingiae) 16-24 part, Fructus Malvae 23-21 part, Caulis seu Radix Schisandrae Henryi 16-23 part, Bombyx Batryticatus 12-18 part.
2. Chinese medicine according to claim 1, is characterized in that, is made up of the raw material of Chinese medicine of following weight portion: Sanguis Draxonis 46 parts, Semen Strychni 41 parts, BIBO 34 parts, Fructus Canarii 29 parts, Medulla Stachyuri (Medulla Helwingiae) 24 parts, Fructus Malvae 21 parts, Caulis seu Radix Schisandrae Henryi 23 parts, Bombyx Batryticatus 18 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201511012476.8A CN105434755A (en) | 2015-12-31 | 2015-12-31 | Traditional Chinese medicine composition for treating digestive tract cancers |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201511012476.8A CN105434755A (en) | 2015-12-31 | 2015-12-31 | Traditional Chinese medicine composition for treating digestive tract cancers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105434755A true CN105434755A (en) | 2016-03-30 |
Family
ID=55545684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201511012476.8A Withdrawn CN105434755A (en) | 2015-12-31 | 2015-12-31 | Traditional Chinese medicine composition for treating digestive tract cancers |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105434755A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102210794A (en) * | 2011-05-30 | 2011-10-12 | 王梅荣 | Silver cicada Chinese medicine preparation for treating liver cancer, esophagus cancer and gastric cancer and preparation method thereof |
-
2015
- 2015-12-31 CN CN201511012476.8A patent/CN105434755A/en not_active Withdrawn
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102210794A (en) * | 2011-05-30 | 2011-10-12 | 王梅荣 | Silver cicada Chinese medicine preparation for treating liver cancer, esophagus cancer and gastric cancer and preparation method thereof |
Non-Patent Citations (3)
| Title |
|---|
| 张显臣: "《名老中医张显臣60年重要应用经验》", 28 February 2014, 山西科学技术出版社 * |
| 杨卫平等: "《新编中草药图谱及经典配方》", 31 May 2014, 贵州科技出版社 * |
| 程爵棠: "《虫蛇妙方》", 31 January 2015, 人民军医出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100593417C (en) | Chinese traditional medicine for treating gastric cancer and bone cancer | |
| CN101036732B (en) | Chinese medicine preparation for esophagus cancer and its compounding process | |
| CN103919895B (en) | The Chinese medicinal liquor of a kind of the intestines and stomach coordinating, treatment constipation | |
| CN102274428B (en) | Pharmaceutical composition with effect on treating irritable bowel syndrome and preparation method and application thereof | |
| CN102697924A (en) | Semen myristicae Chinese medicinal preparation for treating diarrhea and preparation method thereof | |
| CN105434755A (en) | Traditional Chinese medicine composition for treating digestive tract cancers | |
| CN105434757A (en) | Traditional Chinese medicine composition for treating digestive tract cancers | |
| CN105726634A (en) | Traditional Chinese medicine preparation for treating rhinitis | |
| CN101919967B (en) | Traditional Chinese drug for treating esophagus cancer | |
| CN105434754A (en) | Medicine for treating digestive tract cancers | |
| CN100391525C (en) | Chinese medicine preparation for curing eophagus cancer | |
| CN105434756A (en) | Medicine for treating digestive tract cancers | |
| CN104398667A (en) | Traditional Chinese medicinal preparation for treating leucopenia after radiotherapy | |
| CN104491316B (en) | A kind of Chinese medicine preparation for the treatment of deficiency of QI in middle-JIAO type hyperplasia of prostate | |
| CN102872401A (en) | Traditional Chinese medicine preparation for treating non-ulcer dyspepsia | |
| CN103919988B (en) | A kind of the intestines and stomach coordinating, treatment constipation Chinese medicinal liquor | |
| CN102366522B (en) | Chinese medicine pill for treating esophageal cancer and process technology | |
| CN101953963B (en) | Traditional Chinese medicinal preparation for treating brain and renal function failure | |
| CN106390018A (en) | Choleretic Chinese patent medicine | |
| CN105456603A (en) | Traditional Chinese medicine preparation for treating digestive tract cancer | |
| CN105412450A (en) | Traditional Chinese medicine preparation treating digestive tract cancers | |
| CN100998752A (en) | Traditional Chinese medicine decoction for treating radiation stomatitis | |
| CN101214364B (en) | Chinese medicine preparation for treating esophagus cancer and stomach cancer | |
| CN101979051A (en) | Traditional Chinese medicine for treating chronic gastritis | |
| CN102836343B (en) | Medicine for colon nursing and colitis treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160330 |
|
| WW01 | Invention patent application withdrawn after publication |